2014 Report on the Milestones for the US National Plan to Address Alzheimer's Disease.
about
Computerised cognition-based interventions for maintaining cognitive function in cognitively healthy people in midlifeComputerised cognition-based interventions for maintaining cognitive function in cognitively healthy people in late lifeComputerised cognition-based interventions for preventing dementia in people with mild cognitive impairmentSystems biology of neurodegenerative diseasesA rationally designed small molecule for identifying an in vivo link between metal-amyloid-β complexes and the pathogenesis of Alzheimer's disease.Inverse correlation between Alzheimer's disease and cancer: implication for a strong impact of regenerative propensity on neurodegeneration?Prevalence of Dementia and Cognitive Complaints in the Context of High Cognitive Reserve: A Population-Based StudyViscoelastic and ultrastructural characteristics of whole blood and plasma in Alzheimer-type dementia, and the possible role of bacterial lipopolysaccharides (LPS)Vascular and Metabolic Factors in Alzheimer's Disease and Related Dementias: IntroductionRare Genetic Variant in SORL1 May Increase Penetrance of Alzheimer's Disease in a Family with Several Generations of APOE-ɛ4 HomozygosityApproaches for discovering anti-prion compounds: lessons learned and challenges ahead.Ceramide and Its Related Neurochemical Networks as Targets for Some Brain Disorder Therapies.Impact of physiological, pathological and environmental factors on the expression and activity of human cytochrome P450 2D6 and implications in precision medicine.Repetitive transcranial magnetic stimulation (rTMS) combined with cognitive training is a safe and effective modality for the treatment of Alzheimer's disease: clinical experience.The role of melatonin in the onset and progression of type 3 diabetes.Alzheimer Café: an approach focused on Alzheimer's patients but with remarkable values on the quality of life of their caregivers.Streamlining review of research involving humans: Canadian models.Targeting the HDAC2/HNF-4A/miR-101b/AMPK Pathway Rescues Tauopathy and Dendritic Abnormalities in Alzheimer's Disease.Identification of abelson tyrosine kinase inhibitors as potential therapeutics for Alzheimer's disease using multiple e-pharmacophore modeling and molecular dynamics.Computerized Cognitive Training Is Beneficial for Older Adults.Design, synthesis and evaluation of 2-aryl benzoxazoles as promising hit for the A2A receptor.[Clinically validated molecular biomarkers of neurodegenerative dementia].What features of stigma do the public most commonly attribute to Alzheimer's disease dementia? Results of a survey of the U.S. general public.Advances in Alzheimer's imaging are changing the experience of Alzheimer's disease.Synthesis and molecular docking studies of some 4-phthalimidobenzenesulfonamide derivatives as acetylcholinesterase and butyrylcholinesterase inhibitors.
P2860
Q26471271-2903E715-7084-4D84-830A-BB49BF01ABF1Q26471276-8E93F7D1-51D0-4E55-BC12-293453B64488Q26471295-6F25B8E8-1E60-4A59-85E9-712DA9BB98DEQ28080741-A21EC6EF-739F-4E85-8AE1-B1631B63DED0Q33863553-D8E91070-C1B9-4E34-AF91-C89561C26DFAQ34515438-A4C23FEF-7AE4-4500-8B02-E63421497BDFQ35782001-6EE0F84D-801F-4E8C-9ED6-79C27A488D79Q36546334-DAD4E142-399E-4C35-BF38-E01BAF7F2DD8Q36840056-C565C437-FA84-421E-AA2A-8BC4896BED32Q37589622-A764388D-3DE3-4692-8829-D7C31E4BB206Q38356026-5463AB2F-EE47-4DD8-B575-F7ABB4FC0360Q38607507-D384D08A-8794-4ED4-93E1-E92E1C534A88Q38634986-186FFCF2-7420-4F14-B053-8A9803047B40Q39387532-401379E3-EEC5-418F-84E2-A56B8FA74572Q41206619-7CAFE27B-54F2-42DB-A12E-486DE5DA4F4FQ47658986-A1EFC1CE-6650-4792-8D4C-356C0B25F431Q48036747-C5304146-D474-4144-A235-9F5ACC4CCE08Q48307542-26D242F7-26BF-4746-937D-E29C3E159F1AQ48829255-D4607209-EAC8-4247-B902-D7EC5F27FD06Q49155576-E8CF3A76-FC1F-4A00-A0D4-37B27E83E03AQ50917169-3D2D6FD9-EBF4-4DC6-AC32-A7DA2DB0B776Q53357937-B1DEA83E-B347-4F45-91F2-1FB36606423AQ53396862-65BA74A4-5473-4ABD-B410-11C4521A983FQ54959287-7D336F13-2AB7-40DC-9AEE-1ED1FEE11F71Q55724156-28B3AE63-3153-4E89-9F51-158DCF1D2F88
P2860
2014 Report on the Milestones for the US National Plan to Address Alzheimer's Disease.
description
2014 nî lūn-bûn
@nan
2014 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
2014 Report on the Milestones for the US National Plan to Address Alzheimer's Disease.
@ast
2014 Report on the Milestones for the US National Plan to Address Alzheimer's Disease.
@en
type
label
2014 Report on the Milestones for the US National Plan to Address Alzheimer's Disease.
@ast
2014 Report on the Milestones for the US National Plan to Address Alzheimer's Disease.
@en
prefLabel
2014 Report on the Milestones for the US National Plan to Address Alzheimer's Disease.
@ast
2014 Report on the Milestones for the US National Plan to Address Alzheimer's Disease.
@en
P2093
P50
P1476
2014 Report on the Milestones for the US National Plan to Address Alzheimer's Disease.
@en
P2093
Alzheimer's Association National Plan Milestone Workgroup
Brenda Plassman
Bruce Lamb
Claudia Kawas
David Drachman
David Morgan
Howard Fillit
Karl Herrup
Keith N Fargo
Laura Gitlin
P304
P356
10.1016/J.JALZ.2014.08.103
P433
P50
P577
2014-10-01T00:00:00Z